Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Sep Sci ; 44(19): 3691-3699, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34347375

ABSTRACT

Two valine carbamate prodrugs of daidzein were designed to improve its bioavailability. To compare the pharmacokinetic behavior of these prodrugs with different protected phenolic hydroxyl groups of daidzein, a rapid and sensitive method for simultaneous quantification of daidzein, its valine carbamate prodrug, and daidzein-7-O-glucuronide in rat plasma was developed and validated in this study. The samples were processed using a fast one-step protein precipitation method with methanol added to 50 µL of plasma and were analyzed by ultra-high performance liquid chromatography with tandem mass spectrometry. To improve the selectivity, peak shape, and peak elution, several key factors, especially stationary phase and the composition of the mobile phase, were tested, and the analysis was performed using the Kinetex® C18 column (100 × 2.1 mm, 2.6 µm) within only 2.6 min under optimal conditions. The established method exhibited good linearity over the concentration range of 2.0-1000 ng/mL for daidzein, and 8.0-4000 ng/mL for the prodrug and daidzein-7-O-glucuronide. The accuracy of the quality control samples was between 95.5 and 110.2% with satisfactory intra- and interday precision (relative standard deviation values < 10.85%), respectively. This sensitive, rapid, low-cost, and high-throughput method was successfully applied to compare the pharmacokinetic behavior of different daidzein carbamate prodrugs.


Subject(s)
Chromatography, High Pressure Liquid/methods , Glucuronides/blood , Isoflavones/blood , Prodrugs/analysis , Tandem Mass Spectrometry/methods , Animals , Carbamates/blood , Carbamates/chemistry , Carbamates/pharmacokinetics , Glucuronides/chemistry , Glucuronides/pharmacokinetics , Isoflavones/chemistry , Isoflavones/pharmacokinetics , Linear Models , Prodrugs/chemistry , Prodrugs/pharmacokinetics , Rats , Reproducibility of Results , Sensitivity and Specificity , Valine/blood , Valine/chemistry , Valine/pharmacokinetics
2.
Article in English | MEDLINE | ID: mdl-34840083

ABSTRACT

Emerging evidence has suggested that bexarotene, a nearly 20-year-old skin cancer drug, may be a potential drug candidate to treat Alzheimer's disease (AD) and other neurodegenerative disorders. As described in this study, a highly sensitive and rapid method, using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to determine bexarotene in mouse plasma and brain tissue, was established and validated for the first time. Single-step protein precipitation utilizing methanol solution (containing 0.05 % acetic acid) as precipitation agent was employed to prepare the samples of plasma and brain tissue. Chromatographic separation in gradient elution mode was conducted via an Agilent ZORBAX SB-C18 column (50 mm × 4.6 mm, 5 µm) employing methanol-ammonium acetate buffer (5 mM, pH adjusted to 4.6 with acetic acid) as mobile phase which flowed at 0.45 mL/min. The total run time was 6 min for each sample. Detection through mass spectrometric technique was operated by selected reaction monitoring (SRM) in negative electrospray ionization mode. The method was linear within the range of 10.0-15000 ng/mL for plasma and 10.0-600 ng/mL for brain tissue homogenate with the lower limit of quantification of 10.0 ng/ml. The plasma or tissue homogenate was only required 20 µL. The intra- and inter-day precision were less than 13.8 %, and the RE was between -7.4 % and 3.4 %. The method was applied to investigate the plasma pharmacokinetics and brain distribution of bexarotene in mice after being intragastrically administered with bexarotene at the dosage of 100 mg/kg. The results showed that both brain and plasma concentrations of bexarotene peaked at 1.0 h. Bexarotene was rapidly eliminated with a half-life of 2.0 h.


Subject(s)
Bexarotene/analysis , Bexarotene/pharmacokinetics , Brain Chemistry/physiology , Chromatography, Liquid/methods , Tandem Mass Spectrometry/methods , Animals , Bexarotene/chemistry , Limit of Detection , Linear Models , Mice , Mice, Inbred C57BL , Reproducibility of Results
3.
J Chromatogr A ; 1653: 462411, 2021 Sep 13.
Article in English | MEDLINE | ID: mdl-34325296

ABSTRACT

In this work, novel dummy molecularly imprinted membranes (MIMs) were fabricated using the nylon-66 (NY-66) membranes as the subtracts based on an eco-friendly "sandwich" technology with less consumption of organic reagents at mild conditions for recognition and extraction of enrofloxacin (ENR) and ciprofloxacin (CIP) in egg samples. The prepared MIMs were characterized by SEM, ATR-FTIR and TGA, showing the successful construction of uniform and porous polymers on the surface of membranes. A series of adsorption affinity tests were investigated, indicating the prepared materials had specific recognition capacity and excellent stability as novel sorbents. Furthermore, Box-Benhnken design (BBD) and single factor investigations were applied to optimize pretreatment procedures, coupling with Ultra High Performance Liquid Chromatograph (UHPLC) detection. The method showed a good correlation (r2>0.9999) within the linear range of 5.0~5000.0 µg kg-1, and limit of detection (LOD) of ENR and CIP were 0.3 and 0.7 µg kg-1, respectively. The mean recovery ranged from 84.5% to 97.0% within relative standard deviations (RSDs) of 10.2%. Finally, ENR and CIP were not detected in 3 batches of egg samples. The current study developed the dummy MIMs as sorbents combined with UHPLC analysis for extraction and detection of target analytes in food matrices.


Subject(s)
Ciprofloxacin , Enrofloxacin , Membranes, Artificial , Molecular Imprinting , Solid Phase Extraction , Adsorption , Chromatography, High Pressure Liquid , Ciprofloxacin/analysis , Ciprofloxacin/isolation & purification , Enrofloxacin/analysis , Enrofloxacin/isolation & purification , Solid Phase Extraction/methods
SELECTION OF CITATIONS
SEARCH DETAIL